by University of Montreal Credit: Pixabay/CC0 Public DomainCanadian scientists have found a new link between two major metabolic diseases: diabetes and steatotic liver disease, commonly known as fatty liver disease. Published in Diabetes, research into the two diseases by Université de Montréal medical professor Jennifer Estall and her team at the Montreal Clinical Research Institute (IRCM)...
Megan Brooks Drinking sugar-laden beverages on a regular basis may increase the risk for liver cancer and death from chronic liver disease, new research suggests. The observational analyses revealed that postmenopausal women who consumed at least one sugar-sweetened beverage daily had an 85% higher risk of developing liver cancer and a 68% higher risk of dying from...
by University of California – San Diego Credit: Pixabay/CC0 Public Domain Researchers at the University of California San Diego School of Medicine have led a study to examine a potential new treatment option for patients with non-alcoholic steatohepatitis (NASH)-related fibrosis. The results, published in the June 24, 2023, online edition of The New England Journal of Medicine, found...
Megan Brooks May 12, 2023 Statins have disease-modifying potential in people with non-cirrhotic chronic liver disease (CLD) by reducing the risk for progression to severe liver disease, new research shows. The Swedish population-based study found that adults with non-cirrhotic CLD who were on statin therapy had a statistically significant 40% lower risk of developing severe liver...
by University of Cambridge Credit: Owlstone Medical Cambridge-based company Owlstone Medical, co-founded by alumnus Billy Boyle, has experienced trial success for its liver disease breath test, following a study involving patients from Addenbrooke’s Hospital. Owlstone Medical is developing a non-invasive, easy-to-use breath test that can be taken in primary care settings for the diagnosis of advanced non-alcoholic steatohepatitis (NASH)—a...
UNIVERSITY OF MISSOURI-COLUMBIA New research from the University of Missouri School of Medicine has established a link between western diets high in fat and sugar and the development of non-alcoholic fatty liver disease, the leading cause of chronic liver disease. The research, based in the Roy Blunt NextGen Precision Health Building at MU, has identified the western diet-induced microbial and...
by Karolinska Institutet Graphical Abstract. Credit: Journal of Hepatology (2023). DOI: 10.1016/j.jhep.2023.01.014 There is currently no drug for treating non-alcoholic fatty liver disease, which affects many people with type 2 diabetes and which can result in other serious liver diseases. A study led by researchers from Karolinska Institutet has now identified a drug candidate for the treatment of fatty...
by University of Southern California Credit: Maliz Ong/public domain The new year has begun, and with it, resolutions for change. A study from Keck Medicine of USC published today in Clinical Gastroenterology and Hepatology gives people extra motivation to reduce fast-food consumption. The study found that eating fast food is associated with nonalcoholic fatty liver disease, a potentially life-threatening condition in...
by UT Southwestern Medical Center Graphical abstract. Credit: Immunity (2022). DOI: 10.1016/j.immuni.2022.11.013 UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of nonalcoholic fatty liver disease and potential liver failure. The finding, published in Immunity, could pave the way for developing therapies to treat nonalcoholic steatohepatitis (NASH). The team led...
by University of California – San Diego Credit: Pixabay/CC0 Public Domain Approximately one-fourth of the general population worldwide has nonalcoholic fatty liver disease, known as NAFLD, an umbrella term for a range of liver conditions affecting people who drink little to no alcohol. NAFLD can lead to cirrhosis, liver cancer and liver failure. In a...
